Kura Oncology Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.2% | +23.4% | -7.0% | -7.0% | +58.8% | -2.2% | -8.2% | -4.8% | +13.7% | -11.6% | -9.9% | |
| – | -6.0% | +24.4% | -7.1% | -7.3% | +60.8% | -2.8% | -8.9% | -6.0% | +14.2% | -12.0% | -10.3% | |
| – | +29.8% | +11.2% | +8.9% | +9.5% | +353.6% | -77.2% | +59.8% | +16.3% | +56.5% | -73.8% | +79.7% | |
| – | -6.3% | +24.3% | -6.8% | -7.4% | +59.8% | -9.5% | -4.2% | -12.9% | +21.4% | -13.0% | -10.6% | |
| – | – | – | – | – | – | +699.1% | -90.6% | +757.8% | -67.9% | +8.3% | -30.8% | |
| – | – | – | – | – | – | – | – | – | – | +104.1% | +194.8% | |
| – | +17.9% | -5.5% | +0.5% | +12.3% | +529.3% | +9.5% | -0.6% | +7.9% | +38.7% | -3.5% | -1.0% | |
| – | +28.1% | -8.5% | +3.7% | +20.7% | +95.0% | +14.0% | +19.4% | +13.2% | -3.6% | -13.2% | +16.5% | |
| – | -10.5% | -9.5% | +69.8% | +47.2% | +31.8% | -14.8% | +25.7% | +19.9% | -77.9% | +0.5% | +329.3% | |
| – | +30.5% | +227.3% | -72.6% | +45.6% | -51.1% | +213.8% | -63.0% | +174.1% | +7.4% | +40.4% | -66.0% | |
| – | +0.5% | +0.5% | -8.5% | -9.5% | -10.8% | +10.6% | -14.9% | -18.0% | +82.0% | +0.4% | -42.8% | |
| – | -7.6% | +27.1% | -7.7% | -9.1% | -2.4% | -11.9% | -16.2% | -20.6% | -28.2% | -38.0% | -55.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +8.5% | +3.3% | +0.4% | +0.2% | +0.3% | +0.2% | +0.1% | +0.5% | +0.6% | +0.3% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.